|
Market Closed -
Euronext Paris
11:55:00 2026-08-21 am EDT
|
5-day change | 1st Jan Change | ||
| 78.94 EUR | +1.48% |
|
+4.53% | -4.57% |
| Aug. 21 | Sanofi Shuts Down RSV Vaccine Clinical Trial For Infants And Toddlers After Infant Death | CI |
| Aug. 20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| Market Cap | 94.58B 110B 88.43B 80.96B 152B 10,571B 154B 1,046B 407B 5,306B 415B 406B 17,561B | P/E 2026 * |
12.5x | P/E 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 106B 124B 99.11B 90.74B 170B 11,847B 173B 1,172B 457B 5,947B 465B 455B 19,680B | EV / Sales 2026 * |
2.23x | EV / Sales 2027 * | 2.03x |
| Free-Float |
88.34% | Yield 2026 * |
5.39% | Yield 2027 * | 5.7% |
Last Transcript: Sanofi
| 1 day | +1.48% | ||
| 1 week | +4.53% | ||
| Current month | +6.00% | ||
| 1 month | +2.85% | ||
| 3 months | +1.81% | ||
| 6 months | -0.80% | ||
| Current year | -4.57% |
| 1 week | 75.49 |  | 79.07 |
| 1 month | 72.07 | | 80.18 |
| Current year | 71.25 | | 84.97 |
| 1 year | 71.25 | | 91.15 |
| 3 years | 71.25 | | 110.88 |
| 5 years | 71.25 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/6/26 | Others | Executive/Senior Manager | 55,000 | 0.0045% | ||
| 11/15/25 | Buy | Director | 207 | 0.0000% | ||
| 7/29/25 | Buy | Director | 6 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.48% | +4.53% | -9.75% | -19.98% | 110B | |
| +0.88% | +6.38% | +76.86% | +128.23% | 1,119B | |
| +1.07% | +3.80% | +51.03% | +61.48% | 651B | |
| +1.20% | +6.21% | +26.47% | +76.45% | 468B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 374B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 302B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 259B | |
| +1.88% | +5.81% | +48.54% | +68.52% | 238B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 208B | |
| +1.87% | +5.61% | +25.81% | +92.42% | 181B | |
| Average | +1.31% | +4.93% | +27.20% | +45.88% | 391.03B | |
| Weighted average by Cap. | +1.15% | +5.07% | +42.78% | +69.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.59B 55.58B 44.5B 40.74B 76.48B 5,319B 77.48B 526B 205B 2,670B 209B 204B 8,837B | 50.7B 59.21B 47.41B 43.41B 81.48B 5,667B 82.55B 561B 218B 2,845B 222B 217B 9,415B |
| Net income | 7.94B 9.27B 7.43B 6.8B 12.76B 888B 12.93B 87.8B 34.21B 446B 34.81B 34.06B 1,474B | 9.27B 10.82B 8.67B 7.93B 14.89B 1,036B 15.09B 102B 39.92B 520B 40.63B 39.74B 1,721B |
| Net Debt | 11.42B 13.33B 10.67B 9.77B 18.34B 1,276B 18.58B 126B 49.18B 640B 50.05B 48.96B 2,120B | 8.23B 9.61B 7.7B 7.05B 13.23B 920B 13.4B 91.02B 35.47B 462B 36.09B 35.31B 1,529B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | €78.94 | +1.48% | 1,467,583 |
| 26-08-20 | €77.79 | -0.98% | 1,406,571 |
| 26-08-19 | €78.56 | +1.15% | 1,787,672 |
| 26-08-18 | €77.67 | +1.32% | 1,971,698 |
| 26-08-17 | €76.66 | +1.51% | 1,083,029 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
